In AML, BCL11A was shown to repress PU.1 target genes, which is in line with our observation that PU.1 motifs are less accessible in NUP98::KDM5A AML cells, and high expression of BCL11A is linked to worse prognosis in AML patients69,70. The gene discussed is BCL11A; the disease is acute myeloid leukemia.